Align technology announces $100 million accelerated stock repurchase program

Tempe, ariz., nov. 01, 2021 (globe newswire) -- align technology, inc. (“align”) (nasdaq: algn) a leading global medical device company that designs, manufactures, and sells the invisalign system of clear aligners, itero intraoral scanners, and exocad cad/cam software for digital orthodontics and restorative dentistry, today announced that it has entered into a new accelerated stock repurchase agreement ("asr") with citibank, n.a., to repurchase $100 million of align's common stock under align's $1.0 billion stock repurchase program announced on may 13, 2021.
ALGN Ratings Summary
ALGN Quant Ranking